[Ip-health] Economic Times: Compulsory licensing hit India’s image: Hetero Pharma

Thiru Balasubramaniam thiru at keionline.org
Tue Mar 31 04:49:36 PDT 2015


MUMBAI: In what is seen as a contrarian stand adopted by an Indian drug
maker over intellectual property (IP), Hyderabad based Hetero Pharma said
that the country has lost nearly $10 billion worth of investment by not
respecting IP norms. "The Compulsory Licence (CL) that we issued did more
harm to our image than actually helped patients," Srinivas Reddy, director,
Hetero Pharma, told ET.

Read more at:

More information about the Ip-health mailing list